rs11879596
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_145045.5(ODAD3):c.729C>T(p.Asn243Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0138 in 1,614,060 control chromosomes in the GnomAD database, including 177 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 17 hom., cov: 31)
Exomes 𝑓: 0.014 ( 160 hom. )
Consequence
ODAD3
NM_145045.5 synonymous
NM_145045.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.162
Publications
7 publications found
Genes affected
ODAD3 (HGNC:28303): (outer dynein arm docking complex subunit 3) This gene encodes a protein containing coiled-coil domains. The encoded protein functions in outer dynein arm assembly and is required for motile cilia function. Mutations in this gene result in primary ciliary dyskinesia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]
ODAD3 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 30Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 19-11426557-G-A is Benign according to our data. Variant chr19-11426557-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 241946.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.162 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0115 (1747/152218) while in subpopulation NFE AF = 0.0163 (1107/67996). AF 95% confidence interval is 0.0155. There are 17 homozygotes in GnomAd4. There are 824 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 17 AD,AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ODAD3 | NM_145045.5 | c.729C>T | p.Asn243Asn | synonymous_variant | Exon 6 of 13 | ENST00000356392.9 | NP_659482.3 | |
| ODAD3 | NM_001302453.1 | c.567C>T | p.Asn189Asn | synonymous_variant | Exon 6 of 13 | NP_001289382.1 | ||
| ODAD3 | NM_001302454.2 | c.549C>T | p.Asn183Asn | synonymous_variant | Exon 4 of 11 | NP_001289383.1 | ||
| ODAD3 | XM_017026241.2 | c.729C>T | p.Asn243Asn | synonymous_variant | Exon 6 of 9 | XP_016881730.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0115 AC: 1743AN: 152100Hom.: 17 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
1743
AN:
152100
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0123 AC: 3061AN: 249360 AF XY: 0.0128 show subpopulations
GnomAD2 exomes
AF:
AC:
3061
AN:
249360
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0140 AC: 20503AN: 1461842Hom.: 160 Cov.: 33 AF XY: 0.0141 AC XY: 10268AN XY: 727224 show subpopulations
GnomAD4 exome
AF:
AC:
20503
AN:
1461842
Hom.:
Cov.:
33
AF XY:
AC XY:
10268
AN XY:
727224
show subpopulations
African (AFR)
AF:
AC:
70
AN:
33480
American (AMR)
AF:
AC:
288
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
AC:
175
AN:
26132
East Asian (EAS)
AF:
AC:
1
AN:
39700
South Asian (SAS)
AF:
AC:
1001
AN:
86258
European-Finnish (FIN)
AF:
AC:
1251
AN:
53412
Middle Eastern (MID)
AF:
AC:
67
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
16826
AN:
1111984
Other (OTH)
AF:
AC:
824
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1256
2513
3769
5026
6282
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
606
1212
1818
2424
3030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0115 AC: 1747AN: 152218Hom.: 17 Cov.: 31 AF XY: 0.0111 AC XY: 824AN XY: 74420 show subpopulations
GnomAD4 genome
AF:
AC:
1747
AN:
152218
Hom.:
Cov.:
31
AF XY:
AC XY:
824
AN XY:
74420
show subpopulations
African (AFR)
AF:
AC:
95
AN:
41534
American (AMR)
AF:
AC:
130
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
15
AN:
3466
East Asian (EAS)
AF:
AC:
1
AN:
5188
South Asian (SAS)
AF:
AC:
49
AN:
4828
European-Finnish (FIN)
AF:
AC:
257
AN:
10614
Middle Eastern (MID)
AF:
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1107
AN:
67996
Other (OTH)
AF:
AC:
23
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
92
183
275
366
458
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
11
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Primary ciliary dyskinesia 30 Benign:2
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oct 13, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
May 04, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.